Acute Generalized Exanthematous Pustulosis in Close Temporal Association with mRNA-1273 Vaccine

Authors

  • Fouad Mitri Department of Dermatology, University Hospital Heidelberg, DE-69120 Heidelberg, Germany
  • Ferdinand Toberer
  • Alexander H. Enk
  • Martin Hartmann

DOI:

https://doi.org/10.2340/actadv.v101.443

Abstract

Abstract is missing (Short communication)

Downloads

Download data is not yet available.

References

Szatkowski J, Schwartz RA. Acute generalized exanthematous pustulosis (AGEP): a review and update. J Am Acad Dermatol 2015; 73: 843-848.

https://doi.org/10.1016/j.jaad.2015.07.017 DOI: https://doi.org/10.1016/j.jaad.2015.07.017

Hadavand MA, Kaffenberger B, Trinidad JC. Clinical presentation and management of atypical and recalcitrant acute generalized exanthematous pustulosis (AGEP). J Am Acad Dermatol 2020 Sep 11. [Epub ahead of print].

https://doi.org/10.1016/j.jaad.2020.09.024 DOI: https://doi.org/10.1016/j.jaad.2020.09.024

Kardaun SH, Kuiper H, Fidler V, Jonkman MF. The histopathological spectrum of acute generalized exanthematous pustulosis (AGEP) and its differentiation from generalized pustular psoriasis. J Cutan Pathol 2010; 37: 1220-1229.

https://doi.org/10.1111/j.1600-0560.2010.01612.x DOI: https://doi.org/10.1111/j.1600-0560.2010.01612.x

Beltraminelli HS, Lerch M, Arnold A, Bircher AJ, Haeusermann P. Acute generalized exanthematous pustulosis induced by the antifungal terbinafine: case report and review of the literature. Br J Dermatol 2005; 152: 780-783.

https://doi.org/10.1111/j.1365-2133.2005.06393.x DOI: https://doi.org/10.1111/j.1365-2133.2005.06393.x

Pezzarossa E, Ungari M, Caresana G, Sagradi F, Cimardi L, Pan A, et al. Acute generalized exanthematous pustulosis (AGEP) in 12 patients treated for SARS-CoV-2 positive pneumonia. Am J Dermatopathol 2021; 43: 342-348.

https://doi.org/10.1097/DAD.0000000000001819 DOI: https://doi.org/10.1097/DAD.0000000000001819

Nobari NN, Seirafianpour F, Mashayekhi F, Goodarzi A. A systematic review on treatment-related mucocutaneous reactions in COVID-19 patients. Dermato Ther 2021; 34: e14662.

https://doi.org/10.1111/dth.14662 DOI: https://doi.org/10.1111/dth.14662

Lospinoso K, Nichols CS, Malachowski SJ, Mochel MC, Nutan F. A case of severe cutaneous adverse reaction following administration of the Janssen Ad26.COV2.S COVID-19 vaccine. JAAD Case Rep 2021; 13: 134-137.

https://doi.org/10.1016/j.jdcr.2021.05.010 DOI: https://doi.org/10.1016/j.jdcr.2021.05.010

Kang SY, Park SY, Kim JH, Lee SM, Lee SP. COVID-19 vaccine-induced acute generalized exanthematous pustulosis. Korean J Intern Med 2021; 36: 1537-1538.

https://doi.org/10.3904/kjim.2021.198 DOI: https://doi.org/10.3904/kjim.2021.198

Agaronov A, Makdesi C, Hall CS. Acute generalized exanthematous pustulosis induced by Moderna COVID-19 messenger RNA vaccine. JAAD Case Rep 2021; 16: 96-97.

https://doi.org/10.1016/j.jdcr.2021.08.013 DOI: https://doi.org/10.1016/j.jdcr.2021.08.013

Downloads

Published

2021-11-17

How to Cite

Mitri, F., Toberer, F., Enk, A. H., & Hartmann, M. (2021). Acute Generalized Exanthematous Pustulosis in Close Temporal Association with mRNA-1273 Vaccine. Acta Dermato-Venereologica, 101(11), adv00596. https://doi.org/10.2340/actadv.v101.443